Connect with us

Cannabis

Sibannac, Inc. Expands Alternative Health Footprint Entering Pet Market with Distribution Rights to Revolutionary Insect Repelling Collar

Published

on

Scottsdale, Arizona–(Newsfile Corp. – July 5, 2023) –  Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:

Sibannac, Inc., through its wholly-owned alternative health subsidiary, Immersive Brand Concepts, is excited to announce its newest, exclusive partnership with the creators of a groundbreaking dog collar that harnesses the power of pheromones to repel insects. This revolutionary concept has the potential to transform the way pet owners interact with their beloved furry companions.

Designed by Blue Green Earth Sciences out of Oklahoma, this state-of-the-art collar utilizes natural pheromones–which have been proven to repel a wide range of insects, including fleas, ticks and even pesky mosquitoes, without using harmful chemicals or toxins.

“We are incredibly excited to be at the forefront of this game-changing innovation in pet care,” commented David Mersky, CEO of SIBANNAC, Inc., parent to Immersive Brand Concepts. “Part of our core values and mission statement embodies the eternal bond between pets and their owners. And this revolutionary dog collar aligns perfectly with that vision! It has the potential to improve the well-being and quality of life for countless dogs while providing peace of mind to their owners.” The addition of this innovative technology is consistent with Sibannac’s path in alternative wellness. This product will complement the company’s ingestible pet line, including CBD tinctures formulated for dogs and cats.

The company’s strong and ever-evolving partnerships with global retailers and the leading eCommerce platforms enables easy access to this revolutionary product, ensuring that pet owners everywhere can provide their four-legged companions with the protection they deserve from intrusive insects, and all without compromising comfort or wellness in the process.

“This dog collar is unlike any other you’ve seen come to market yet,” states Michael Lazar, Chief Marketing Officer (CMO) of Immersive. “Using advanced science combined with a comprehensive approach to pet engineering, this collar turns your dog into a biological insect defensive mechanism — which means that it will now naturally curb annoying and disease-carrying pests like mosquitoes, flies, fleas and ticks! And all the while, Fido’s going to be super comfy, happier and healthier to boot… and we think that’s something to ‘woof!’ about!”

Immersive Brand Concepts will be unveiling further details, including the product’s name, pricing, and availability, in the near future. Stay tuned for updates on this exciting breakthrough in pet care.

About Sibannac

Sibannac, Inc. (OTC Pink: SNNC) is a Nevada corporation founded in 1999 and located in Scottsdale, Arizona. Sibannac currently specializes in creating and selling premium next generation wellness products in the consumer packaging goods space. In addition to mainstream supplements, the Company is producing Kratom and Hemp-derived Delta-8/9 products, Kratom, and Amanita mushroom edibles for wholesale and retail sales and distribution. Sibannac provides contract manufacturing and white labeling services for independent firms and creates and manages its own brands from the concept phase through to distribution. Sibannac has opened its platform to outside clients to offer its marketing and brand-building assets, through its wholly owned subsidiary, The Campus Co., led by Eric Stoll, Sibannac’s Chief Marketing Officer. The Campus is already providing services to leading wellness brands.

More from Sibannac – For additional information and product updates, please follow us at The Campus Co. and follow us on Twitter at www.twitter.com/sibannacinc.

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/172319

Cannabis

Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care

Published

on

Continue Reading

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania